Investment House LLC Boosts Stake in Invesco Biotechnology & Genome ETF (NYSEARCA:PBE)

Investment House LLC increased its holdings in shares of Invesco Biotechnology & Genome ETF (NYSEARCA:PBE) by 4.5% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 7,980 shares of the company’s stock after acquiring an additional 345 shares during the period. Investment House LLC owned approximately 0.20% of Invesco Biotechnology & Genome ETF worth $531,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of the business. Raymond James Financial Inc. purchased a new stake in shares of Invesco Biotechnology & Genome ETF during the fourth quarter worth $1,256,000. Jane Street Group LLC purchased a new stake in Invesco Biotechnology & Genome ETF during the 3rd quarter worth about $295,000. Commonwealth Equity Services LLC increased its holdings in Invesco Biotechnology & Genome ETF by 16.9% during the 4th quarter. Commonwealth Equity Services LLC now owns 26,002 shares of the company’s stock worth $1,730,000 after purchasing an additional 3,764 shares during the period. HighTower Advisors LLC raised its position in Invesco Biotechnology & Genome ETF by 64.1% in the 3rd quarter. HighTower Advisors LLC now owns 7,101 shares of the company’s stock valued at $494,000 after purchasing an additional 2,774 shares in the last quarter. Finally, Farther Finance Advisors LLC purchased a new position in shares of Invesco Biotechnology & Genome ETF in the 4th quarter valued at about $161,000.

Invesco Biotechnology & Genome ETF Stock Performance

PBE stock opened at $66.11 on Thursday. The company’s 50 day moving average price is $67.60 and its 200 day moving average price is $68.60. The firm has a market capitalization of $241.96 million, a price-to-earnings ratio of 22.64 and a beta of 0.80. Invesco Biotechnology & Genome ETF has a fifty-two week low of $59.32 and a fifty-two week high of $72.84.

About Invesco Biotechnology & Genome ETF

PowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies.